4月1日 - ** 药物开发商 Fractyl Health GUTS.O股价盘前上涨 6.7% 至 1.27 美元
** 该公司称，早期数据显示，其体重管理设备Revita有助于患者在停止服用减肥药后保持体重
** 术后一个月，七名患者的平均体重反弹率仅为 1.2%，而根据之前的临床研究，停用 GLP-1 后这一时期的反弹率通常为 3% - GUTS
** 公司预计将在今年第三季度公布该研究的其他数据
** 公司股价今年以来下跌了 42.2
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.